SCN1A and encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy: Of particular interest, the significantly lowered PRS for intelligence in our cohort could imply that even with symptomatic treatment leading to seizure freedom, or with disease-modifying treatment increasing SCN1A expression, the full phenotype of Dravet syndrome may not be entirely reversible.